Clinical Trials Logo

Gestational Diabetes Mellitus clinical trials

View clinical trials related to Gestational Diabetes Mellitus.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03912363 Active, not recruiting - Clinical trials for Gestational Diabetes Mellitus

Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

This study will determine whether rotating intravenous (IV) fluid is better than receiving insulin to control a baby's blood sugar after delivery in laboring women with diabetes. A computer will choose the method of controlling the participant's blood sugar while they are in labor.

NCT ID: NCT03246295 Active, not recruiting - Clinical trials for Gestational Diabetes Mellitus

Identification of Gestational Diabetes Mellitus Related Urinary Biomarkers Along Pregnancy (From Early Pregnancy to Postpartum) by Using Proteomics and Metabolomics Analysis

Start date: October 20, 2015
Phase: N/A
Study type: Observational

Gestational diabetes mellitus (GDM) has many adverse effects on pregnant women and fetuses. At present, no prediction marker for GDM in early pregnancy is accepted. There is still a lack of recognized early predictors. This study was designed to identity valuable biomarkers for GDM.This was a prospective observed cohort study. 140 pregnant women were recruited in early pregnancy, and followed up to 6 weeks postpartum. Glucose challenge test and 75g oral glucose tolerance test were performed after 24 weeks of pregnancy, and GDM was diagnosed according to the latest ADA standard. Urinary samples were collected in the first (<12 weeks), second (24~28 weeks) and third (32~weeks) trimester of pregnancy. Urinary proteomics and metabolomics were analyzed by ultra-performance liquid chromatography tandem mass spectrometry. 15 cases of GDM women and 50 cases of control women were used for longitudinal analysis; 15 cases of GDM women and 15 cases of age matched control women were used for difference analysis.

NCT ID: NCT03073551 Active, not recruiting - Clinical trials for Gestational Diabetes Mellitus

The Impact of Activity Promoting Video Games on Glycemic Control in Gestational Diabetes Mellitus

Start date: July 27, 2010
Phase: N/A
Study type: Interventional

Gestational diabetes mellitus (GDM) affects up to 3-5% of all pregnancies. When diagnosed with GDM, women undergo nutritional counseling, blood sugars monitoring and are encouraged to exercise regularly. Women who do not meet therapeutic targets may need to add insulin injections. Activity promoting video games are an attractive possibility for improvement of exercise compliance. The objective of this study is to determine whether providing women recently diagnosed with GDM with a Nintendo Wii™ activity promoting gaming platform will increase activity levels, improve glycemic control of sugar levels and decrease the need for supplementary insulin treatment.

NCT ID: NCT03023293 Active, not recruiting - Clinical trials for Gestational Diabetes Mellitus

Effects and Mechanisms of n-3 PUFAs and Irisin on Abnormal Glucose Metabolism After GDM.

Start date: March 10, 2017
Phase:
Study type: Observational

The purpose of this study is to clarify the relationship between n-3 PUFA and irisin in regulating the glucose metabolism in GDM patients.

NCT ID: NCT01817127 Active, not recruiting - Healthy Clinical Trials

Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study

Start date: April 1, 2009
Phase:
Study type: Observational

This observational study is designed to determine how sugars, lipids and proteins in breast milk vary among mothers; is affected by maternal diet, health and microbiota and vary over the course of lactation. Additionally, the study is designed to determine how the structure and composition of complex milk sugars, maternal health status and diet influence the development and maintenance of infant gut microflora.

NCT ID: NCT01329016 Active, not recruiting - Clinical trials for Gestational Diabetes Mellitus

Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)

GDM
Start date: July 2011
Phase: Phase 1/Phase 2
Study type: Interventional

This is a pharmacokinetic and pharmacodynamic study evaluating glyburide, metformin, and combination treatment for gestational diabetes mellitus.